Cite
HARVARD Citation
Soo, R. et al. (n.d.). LBA18Survival and treatment patterns in patients (pts) with locally advanced or metastatic NSCLC treated with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIS): Analysis of US insurance claims databases. Annals of oncology. p. . [Online].